Kuptimi i marrëdhënieve midis terapisë MRD dhe CAR T-Cell
What is MRD in cancer treatment? Measurable Residual Disease, or MRD, is the name for the very few cancer cells that stay in the body after or during treatment. Flow cytometry, polymerase chain reaction (PCR), or next-generati..
Terapia e qelizave staminale mezenkimale në çrregullimet neurologjike
Neurological diseases are big problems around the world because they cause a lot of death and disability. Traditional treatments haven't always worked, which has led to a change toward new methods like cell-based therapies. Beca..
Emërtimi i barit jetim është dhënë nga FDA në CART T-Cell Therapy A2B530 për trajtimin e kancerit kolorektal
In March 2024, a news release said that A2B530 (A2 Biotherapeutics), a CAR T-cell therapy, had been given Orphan Drug Designation to treat colorectal cancer that expresses carcinoembryonic antigen (CEA) and has lost HLA-A*02 expr..
Amtagvi i Iovance është miratuar nga USFDA si terapia e parë me qeliza T për një tumor solid
Iovance Biotherapeutics' first-of-its-kind immunotherapy was approved by the FDA. This means that T-cell therapy, which has changed the way some types of blood cancer are treated, can now be used directly on solid tumors.The drug..
Amivantamab-vmjw është miratuar nga USFDA për indikacionet e kancerit të mushkërive me qeliza jo të vogla me mutacion të EGFR të ekzonit 20
The Food and Drug Administration approved amivantamab-vmjw (Rybrevant, Janssen Biotech, Inc.) in combination with carboplatin and pemetrexed on March 1, 2024. Patients with epidermal growth factor receptor (EGFR) exon 20 insertio..
Osimertinib me kimioterapi është miratuar nga USFDA për kancerin e mushkërive me qeliza jo të vogla të mutuara nga EGFR
The Food and Drug Administration approved osimertinib (Tagrisso, AstraZeneca Pharmaceuticals LP) in combination with platinum-based chemotherapy for patients with locally advanced or metastatic non-small cell lung cancer (la/mNSC..
Lifileucel është aprovuar nga USFDA për melanomën e pakapshme ose metastatike
The Food and Drug Administration granted accelerated approval to lifileucel (Amtagvi, Iovance Biotherapeutics, Inc.) on February 16, 2024. This approval is for adult patients with unresectable or metastatic melanoma who have been..
Tepotinib është miratuar nga USFDA për kancerin metastatik të mushkërive me qeliza jo të vogla
The Food and Drug Administration officially approved tepotinib (Tepmetko, EMD Serono, Inc.) on February 15, 2024, for adult patients with metastatic non-small cell lung cancer (NSCLC) that had mesenchymal-epithelial transition (M..
Liposome irinotecan është miratuar nga USFDA për trajtimin e linjës së parë të adenokarcinomës pankreatike metastatike
The Food and Drug Administration approved irinotecan liposome (Onivyde, Ipsen Biopharmaceuticals, Inc.) with oxaliplatin, fluorouracil, and leucovorin on February 13, 2024, for treating metastatic pancreatic adenocarcinoma as the..
Erdafitinib është miratuar nga USFDA për karcinomën uroteliale të avancuar lokalisht ose metastatike
Erdafitinib (Balversa, Janssen Biotech) was approved by the Food and Drug Administration on January 19, 2024, for adult patients with FGFR3 genetic changes who have locally advanced or metastatic urothelial carcinoma (mUC). Patie..